Skip to main content

Breast Cancer

Breast Cancer

Polyunsaturated Fatty Acids, Exercise, and Fatigue in Breast Cancer

Breast Cancer

Highlights in Breast Cancer from ASCO 2021: An Interview with Virginia Kaklamani, MD

Case Reports, Breast Cancer, Adverse Events

Hypersensitivity Reactions to Taxanes and Subsequent Treatment with Nab-Paclitaxel: Case Reports of 2 Women with Early-Stage Breast Cancer

Kevin Straughn, PharmD, Robin Hardie-Hood, MD, Jordan Carrera, PharmD, BCPS, BCOP

Kevin Straughn, PharmD; Robin Hardie-Hood, MD; Jordan Carrera, PharmD, BCPS, BCOP

From the Literature, Breast Cancer, Dose Escalation/Reduction

Low-Dose Capecitabine Maintenance Therapy Improves Survival in Patients with Triple-Negative Breast Cancer

Robert J. Ignoffo, PharmD, FASHP, FCSHP, FHOPA

Breast Cancer, FDA Updates

FDA Approves Margenza for Treatment of Metastatic HER2-Positive Breast Cancer

FDA Updates, Breast Cancer

FDA Approves Margenza for the Treatment of Metastatic HER2-Positive Breast Cancer

Breast Cancer

Breast Cancer Year in Review Introduction

Breast Cancer

Retrospective Analysis Provides Insight into Treatment-Emergent Neutropenia Among Patients with Metastatic Breast Cancer Treated with Ribociclib or Palbociclib

Breast Cancer, CDK4/6 Inhibitors

Concurrent Use of Medications with Potential Drug–Drug Interactions: Real-World Analysis of Patients Treated with CDK4/6 Inhibitors

Breast Cancer

Abemaciclib plus Fulvestrant Provides Statistically Significant Benefit as First- and Second-Line Therapy for Hormone Receptor–Positive, HER2-Negative Advanced Breast Cancer

3
4
5
6
7
8
9

Page 6 of 12
Results 51 - 60 of 114